Jennie Orr Appointed Chief Strategy and Business Officer at Camargo Pharmaceutical Services, LLC

CINCINNATI, Oct. 13, 2020 /PRNewswire/ — Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced today the appointment of Jennie Orr as Chief Strategy and Business Officer. In this newly created senior leadership role, Orr will lead the development, communication and execution of corporate strategic growth initiatives including both organic growth and its mergers and acquisitions activities.

“Jennie has consistently demonstrated her strong leadership abilities and her dedication to Camargo’s values since she joined us in 2018,” Camargo CEO Dan Duffy said. “Having her in this position will enable us to advance our operational vision and achieve our growth expectations for the future.”

Camargo is a leading global strategy, regulatory and commercial partner for emerging and mid-size biopharma companies and has been instrumental in helping numerous pharmaceutical companies identify opportunities, develop products and obtain FDA approvals. Its work in orphan drugs, improved drugs, oncology and many

Read More

Ludovic Blanquet Joins smartTrade as Chief Product and Strategic Planning Officer

LONDON & AIX-EN-PROVENCE, France–(BUSINESS WIRE)–smartTrade Technologies today announces that Ludovic Blanquet has joined as Chief Product and Strategic Planning Officer. Ludovic will support smartTrade to deliver world class integrated eTrading solutions.

Ludovic brings 20 years of industry experience to the role. He joins from Finastra where he was the Global Head of Product Strategy across its five lines of business. Prior to this, he built Credit Agricole APAC’s global equities trading platform and was APAC regional director for SmartStream, a corporate banking software vendor. Ludovic has experience working across multiple international markets having lived in Tokyo, London and Singapore during his career.

Ludovic will help shape smartTrade’s vision to deliver the leading cross-asset eTrading solution, capitalising on its market leading eFX LiquidityFX (LFX) cloud offering. Now based in London, Ludovic will lead a team of strategy and product managers responsible for designing and delivering on the future product

Read More

Hyde Engineering + Consulting Announces Appointment of Chief Operating Officer

BOULDER, Colo., Oct. 7, 2020 /PRNewswire/ — Hyde Engineering + Consulting, Inc. (Hyde) a worldwide partner for solution-based pharmaceutical design and consultant services, announced the appointment of Kalpesh Patel as Chief Operating Officer (COO).  Patel will lead Hyde’s growing global enterprise, translating the growth strategies set by Hyde’s Board of Directors and CEO to maximize profitability.

“I’m embracing this role with the focused calm and practical ideology that led me here. As I accept this new challenge, I will be relying on my extremely capable colleagues to work towards Hyde’s global integration, focusing on the consistency of operational processes and efficient utilization of our combined talents. I’m sincerely honored to be selected into this role and will put forth my best efforts to maintain company culture and sustainability, expanding that to Hyde’s global entity,” Kalpesh Patel, COO.

“From first joining the company in 2005, Kalpesh has been and

Read More

Caris Life Sciences Appoints Brian Lamon, Ph.D., as Chief Business Officer, Head of BioPharma Business Development

Lamon to oversee business development strategy and execution, and brings over 15 years of pharmaceutical and academia experience to the company

IRVING, Texas, Oct. 6, 2020 /PRNewswire/ — Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Brian Lamon, Ph.D., has been appointed Chief Business Officer, Head of BioPharma Business Development.

Caris Life Sciences Logo (PRNewsfoto/Caris Life Sciences)
Caris Life Sciences Logo (PRNewsfoto/Caris Life Sciences)

In this role, Lamon will be responsible for developing the partnering and business development strategy for the company and translating that strategy into actionable and achievable goals for the broader Caris organization.

“We are very excited to welcome Brian to Caris,” said Brian J. Brille, Vice Chairman of Caris Life Sciences. “His expertise in oncology clinical development, business development, translational medicine and medical affairs, and track record of maximizing value from external relationships will further advance

Read More